Charles Rhyee
Stock Analyst at TD Cowen
(0.93)
# 3,895
Out of 5,022 analysts
55
Total ratings
36.36%
Success rate
-10.61%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Upgrades: Buy | $297 → $380 | $287.65 | +32.10% | 4 | Oct 7, 2025 | |
| OPCH Option Care Health | Initiates: Hold | $30 | $27.10 | +10.70% | 1 | Oct 2, 2025 | |
| MCK McKesson | Maintains: Buy | $830 → $864 | $781.90 | +10.50% | 4 | Sep 24, 2025 | |
| MEDP Medpace Holdings | Downgrades: Sell | $283 → $366 | $516.93 | -29.20% | 5 | Jul 23, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $254 → $157 | $186.00 | -15.59% | 4 | Apr 14, 2025 | |
| CAH Cardinal Health | Upgrades: Buy | $130 → $144 | $154.19 | -6.61% | 2 | Jan 8, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $170.13 | +33.43% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $9.55 | +161.78% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $8.93 | -10.41% | 6 | Oct 31, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.14 | +286.47% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $5 | $3.05 | +63.93% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $100 → $50 | $5.93 | +743.17% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $204.76 | +22.58% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $8.94 | +526.40% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $360 → $280 | $14.38 | +1,847.15% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $7.71 | +548.51% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $28.00 | +25.00% | 1 | Feb 13, 2018 |
Veeva Systems
Oct 7, 2025
Upgrades: Buy
Price Target: $297 → $380
Current: $287.65
Upside: +32.10%
Option Care Health
Oct 2, 2025
Initiates: Hold
Price Target: $30
Current: $27.10
Upside: +10.70%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $830 → $864
Current: $781.90
Upside: +10.50%
Medpace Holdings
Jul 23, 2025
Downgrades: Sell
Price Target: $283 → $366
Current: $516.93
Upside: -29.20%
ICON Public Limited Company
Apr 14, 2025
Downgrades: Hold
Price Target: $254 → $157
Current: $186.00
Upside: -15.59%
Cardinal Health
Jan 8, 2025
Upgrades: Buy
Price Target: $130 → $144
Current: $154.19
Upside: -6.61%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $170.13
Upside: +33.43%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $9.55
Upside: +161.78%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $8.93
Upside: -10.41%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.14
Upside: +286.47%
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.05
Upside: +63.93%
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $5.93
Upside: +743.17%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $204.76
Upside: +22.58%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $8.94
Upside: +526.40%
Aug 16, 2022
Maintains: Outperform
Price Target: $360 → $280
Current: $14.38
Upside: +1,847.15%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $7.71
Upside: +548.51%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $28.00
Upside: +25.00%